You are here

Article Text

Article menu
Download PDFPDF
Paper
Troponin I in predicting cardiac or pulmonary complications and outcome in subarachnoid haemorrhage
  1. W J Schuiling1,
  2. P J W Dennesen2,
  3. J Th J Tans1,
  4. L M Kingma3,
  5. A Algra5,
  6. G J E Rinkel4
  1. 1Department of Neurology, Medical Centre Haaglanden, Westeinde Hospital, 2512 VA the Netherlands
  2. 2Department of Intensive Care, Medical Centre Haaglanden
  3. 3Department of Radiology, Medical Centre Haaglanden
  4. 4Department of Neurology, University Medical Centre Utrecht, Utrecht, 3584 CX The Netherlands
  5. 5Rudolf Magnus Institute of Neuroscience, and the Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht
  1. Correspondence to:
 Dr W J Schuiling
 Department of Neurology; Medical Centre Leeuwarden, PO Box 888 8901 BR Leeuwarden, The Netherlands; wjschuilingplanet.nl

Abstract

Background: Patients with aneurysmal subarachnoid haemorrhage (SAH) are at risk of cardiac and pulmonary complications. Troponin I (cTnI), a reliable marker of myocardial injury, is frequently raised after SAH.

Aims: To investigate the additional value of (cTnI) in predicting cardiac or pulmonary complications and outcome in patients with SAH.

Methods: Admission cTnI was measured in a prospective series of patients admitted within 24 hours of SAH. By means of univariate and multivariate logistic regression models the additional prognostic value of raised cTnI (>0.3 μg/litre) was investigated compared with established prognosticators (clinical condition on admission, age, and amount of blood on admission computed tomography) for predicting the occurrence of pulmonary oedema, pulmonary gas exchange abnormalities, rhythm disturbances, inadequate cardiac performance, a combination of these complications, and poor outcome. Area under the operator characteristic curve (AUC-ROC) was used to assess additional prognostic value.

Results: Abnormal cTnI concentrations were found on admission in 35 of 68 patients. Abnormal cTnI concentrations and poor clinical condition independently predicted cardiac or pulmonary complications. After extending the model with World Federation of Neurological Surgeons scale and age in addition to abnormal cTnI, the AUC-ROC improved from 0.70 (95% confidence interval (CI), 0.57 to 0.83) to 0.83 (95% CI, 0.72 to 0.93). Abnormal cTnI also independently predicted poor outcome. The additional prognostic value of cTnI for poor outcome is limited.

Conclusions: cTnI measurement is a powerful predictor for the occurrence of pulmonary and cardiac complications, but does not carry additional prognostic value for clinical outcome in patients with aneurysmal SAH.

  • AUC, area under the curve
  • CI, confidence interval
  • CPIS, clinical pulmonary infection score
  • CT, computed tomography
  • cTnI, cardiac troponin I
  • ECG, electrocardiogram
  • FiO2, fraction of inspired oxygen
  • ICU, intensive care unit
  • MAP, mean arterial pressure
  • PaO2, partial pressure of oxygen in arterial blood
  • ROC, operator characteristic curve
  • SAH, subarachnoid haemorrhage
  • SIRS, systemic inflammatory response syndrome
  • WFNS, World Federation of Neurological Surgeons
  • troponin
  • subarachnoid haemorrhage
  • outcome
  • complications

https://doi.org/10.1136/jnnp.2004.060913

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Dr Rinkel is an established clinical investigator of the Netherlands Heart Foundation (grant D98.014).

    • Competing interests: none declared

    • Ethics approval: In this prospective study recording data after routine treatment and no extra patient visiting, submission to our local ethics committee was not required.